首页> 外国专利> In the treatment of developmental disorders, (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino- Use of 4-(difluoromethylidene) cyclopentane -1-carboxylic acid and bigabatrin

In the treatment of developmental disorders, (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino- Use of 4-(difluoromethylidene) cyclopentane -1-carboxylic acid and bigabatrin

机译:在发育障碍的治疗中,(S)-3-氨基-4-(二氟甲基)循环酮-1-烯-1-羧酸和相关化合物,(1S,3S)-3-氨基使用4-(二氟甲基)环戊烷-1-羧酸和巨大碱

摘要

The compound of formula 1 described in the present invention, (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, (1S,3S)-3-amino-4 -(Difluoromethylidene) cyclopentane-1-carboxylic acid, or bagabatrin, or a pharmaceutically acceptable salt of any of the above, with Fragile X Syndrome, Angelman Syndrome, Fragile X-Related Tremor/Ataxia Syndrome, autism spectrum disorder, Asperger's syndrome, Pervasive developmental disorder not otherwise characterized, childhood disintegrative disorder, Williams syndrome, or Jacobsen's syndrome.
机译:本发明中描述的式1的化合物,(S)-3-氨基-4-(二氟甲基)圈 - 1-EnE-1-羧酸,(1S,3S)-3-氨基-4-(二氟甲基)环戊烷-1-羧酸,或巴布巴菊酯,或以上任何一种药学上可接受的盐,用脆弱的X综合征,angelman综合征,脆弱的X相关震颤/共济失调综合征,自闭症谱系疾病,患者的综合症,普及者的综合症紊乱其特征,儿童分解障碍,威廉姆斯综合征,或雅各布森综合症。

著录项

  • 公开/公告号KR20210035802A

    专利类型

  • 公开/公告日2021-04-01

    原文格式PDF

  • 申请/专利权人 오비드 테라퓨틱스 인크.;

    申请/专利号KR1020217000541

  • 发明设计人 듀링 매튜;아브라함스 브렛;

    申请日2019-06-07

  • 分类号A61K31/196;A61K31/197;A61P25/18;A61P43;

  • 国家 KR

  • 入库时间 2022-08-24 18:06:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号